United States· US:49999-046_018c5bb2-b5ea-4e62-8670-3e099c32ead9
Orphenadrine Citrate
A medicinal product containing orphenadrine citrate, registered in United States by Lake Erie Medical DBA Quality Care Products LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ORPHENADRINE CITRATE
- Manufacturer
- Lake Erie Medical DBA Quality Care Products LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1149999-046-60
- ndc11499990466060 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49999-046-60)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Orphenadrine citrate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaSANDOZ ORPHENADRINESANDOZ CANADA INCORPORATED
- FinlandNorflexViatris Oy
- SwedenNorflex 100 mg DepottablettViatris AB
- United KingdomBiorphen 25mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- NorwayDisipalAstellas Pharma AS
- GermanyNorflexViatris Healthcare Gmbh
- ItalyDISIPAL*50 cpr rivestite 50 mgECUPHARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Norflex, Norflex N
- Denmark · Lysantin
- Finland · Norflex
- United Kingdom (Northern Ireland) · Orphenadrine Hydrochloride Rosemont Pharmaceuticals
- Greece · Orphedrin
- Italy · Disipal
- Sweden · Norflex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/25254e14-2694-45fa-ac45-5664ce21a03e GET /v1/drugs/25254e14-2694-45fa-ac45-5664ce21a03e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "ORPHENADRINE CITRATE",
"productndc": "49999-046",
"dosage_form": "TABLET, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA040284",
"marketing_category": "ANDA"
}See everything about orphenadrine citrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.